Episode Details
Back to Episodes
257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business
Published 3 years, 5 months ago
Description
Eli Lilly’s investigational medicine for Alzheimer’s met its goals in an all-important clinical trial, and we explain the results, their implications, and the backstory of what could be a blockbuster drug. We also discuss the latest news in the life sciences, including a busy week of earnings, a long-awaited FDA approval, and the highlights from STAT’s Breakthrough Summit in San Francisco.